Prevail Innovative Wealth Advisors LLC Buys New Shares in iShares U.S. Pharmaceuticals ETF $IHE

Prevail Innovative Wealth Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 53,387 shares of the company’s stock, valued at approximately $4,529,000. Prevail Innovative Wealth Advisors LLC owned approximately 0.48% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently bought and sold shares of IHE. Banque Cantonale Vaudoise purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at about $2,077,000. Csenge Advisory Group purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $271,000. Aviance Capital Partners LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $205,000. AlphaCore Capital LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $262,000. Finally, Financial Partners Group Inc purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $325,000.

iShares U.S. Pharmaceuticals ETF Trading Up 0.8%

NYSEARCA:IHE opened at $89.29 on Thursday. The company has a market capitalization of $964.33 million, a P/E ratio of 17.75 and a beta of 0.49. iShares U.S. Pharmaceuticals ETF has a 12 month low of $63.03 and a 12 month high of $92.29. The business’s 50-day moving average is $86.97 and its 200 day moving average is $86.01.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.